166 related articles for article (PubMed ID: 38824552)
1. PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer.
Curcio C; Mucciolo G; Roux C; Brugiapaglia S; Scagliotti A; Guadagnin G; Conti L; Longo D; Grosso D; Papotti MG; Hirsch E; Cappello P; Varner JA; Novelli F
J Exp Clin Cancer Res; 2024 Jun; 43(1):157. PubMed ID: 38824552
[TBL] [Abstract][Full Text] [Related]
2. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer.
Cappello P; Rolla S; Chiarle R; Principe M; Cavallo F; Perconti G; Feo S; Giovarelli M; Novelli F
Gastroenterology; 2013 May; 144(5):1098-106. PubMed ID: 23333712
[TBL] [Abstract][Full Text] [Related]
4. Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response.
Cappello P; Tonoli E; Curto R; Giordano D; Giovarelli M; Novelli F
Oncoimmunology; 2016 May; 5(5):e1112940. PubMed ID: 27467915
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic DNA vaccine targeting Foxp3
Namdar A; Mirzaei R; Memarnejadian A; Boghosian R; Samadi M; Mirzaei HR; Farajifard H; Zavar M; Azadmanesh K; Elahi S; Noorbakhsh F; Rezaei A; Hadjati J
Cancer Immunol Immunother; 2018 Mar; 67(3):367-379. PubMed ID: 29124314
[TBL] [Abstract][Full Text] [Related]
6. PI3Kγ Activates Integrin α
Foubert P; Kaneda MM; Varner JA
Cancer Immunol Res; 2017 Nov; 5(11):957-968. PubMed ID: 28963139
[TBL] [Abstract][Full Text] [Related]
7. Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.
Cappello P; Curcio C; Mandili G; Roux C; Bulfamante S; Novelli F
Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29462900
[TBL] [Abstract][Full Text] [Related]
8. Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer.
Gunderson AJ; Kaneda MM; Tsujikawa T; Nguyen AV; Affara NI; Ruffell B; Gorjestani S; Liudahl SM; Truitt M; Olson P; Kim G; Hanahan D; Tempero MA; Sheppard B; Irving B; Chang BY; Varner JA; Coussens LM
Cancer Discov; 2016 Mar; 6(3):270-85. PubMed ID: 26715645
[TBL] [Abstract][Full Text] [Related]
9. Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacy.
Muralidhar A; Gamat-Huber M; Vakkalanka S; McNeel DG
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38772685
[TBL] [Abstract][Full Text] [Related]
10. In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination.
Mandili G; Curcio C; Bulfamante S; Follia L; Ferrero G; Mazza E; Principe M; Cordero F; Satolli MA; Spadi R; Evangelista A; Giordano D; Viet D; Cappello P; Novelli F
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115943
[TBL] [Abstract][Full Text] [Related]
11. A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.
Keenan BP; Saenger Y; Kafrouni MI; Leubner A; Lauer P; Maitra A; Rucki AA; Gunderson AJ; Coussens LM; Brockstedt DG; Dubensky TW; Hassan R; Armstrong TD; Jaffee EM
Gastroenterology; 2014 Jun; 146(7):1784-94.e6. PubMed ID: 24607504
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Phosphatidylinositol 3-Kinase γ by IPI-549 Attenuates Abdominal Aortic Aneurysm Formation in Mice.
Liu R; Huang J; Ge Y; Liu S; Huang T; Cai H; Pan B; Zhang Q; Yang P; Liao M; Xu B; Wang W
Eur J Vasc Endovasc Surg; 2020 Aug; 60(2):254-263. PubMed ID: 32423743
[TBL] [Abstract][Full Text] [Related]
13. Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.
Metzger P; Kirchleitner SV; Boehmer DFR; Hörth C; Eisele A; Ormanns S; Gunzer M; Lech M; Lauber K; Endres S; Duewell P; Schnurr M; König LM
Cancer Immunol Immunother; 2020 Oct; 69(10):2101-2112. PubMed ID: 32448983
[TBL] [Abstract][Full Text] [Related]
14. PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses.
Sai J; Owens P; Novitskiy SV; Hawkins OE; Vilgelm AE; Yang J; Sobolik T; Lavender N; Johnson AC; McClain C; Ayers GD; Kelley MC; Sanders M; Mayer IA; Moses HL; Boothby M; Richmond A
Clin Cancer Res; 2017 Jul; 23(13):3371-3384. PubMed ID: 28003307
[No Abstract] [Full Text] [Related]
15. Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.
Principe M; Borgoni S; Cascione M; Chattaragada MS; Ferri-Borgogno S; Capello M; Bulfamante S; Chapelle J; Di Modugno F; Defilippi P; Nisticò P; Cappello P; Riganti C; Leporatti S; Novelli F
J Hematol Oncol; 2017 Jan; 10(1):16. PubMed ID: 28086938
[TBL] [Abstract][Full Text] [Related]
16. Protection against HPV-16-Associated Tumors Requires the Activation of CD8+ Effector Memory T Cells and the Control of Myeloid-Derived Suppressor Cells.
Diniz MO; Sales NS; Silva JR; Ferreira LC
Mol Cancer Ther; 2016 Aug; 15(8):1920-30. PubMed ID: 27222537
[TBL] [Abstract][Full Text] [Related]
17. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.
Oweida AJ; Mueller AC; Piper M; Milner D; Van Court B; Bhatia S; Phan A; Bickett T; Jordan K; Proia T; Schulick R; Messersmith WA; Del Chiaro M; Clambey E; Gough MJ; Williams J; Hansen K; Goodman K; Karam SD
Cancer Immunol Immunother; 2021 Apr; 70(4):989-1000. PubMed ID: 33097963
[TBL] [Abstract][Full Text] [Related]
18. Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition.
Carnevalli LS; Taylor MA; King M; Coenen-Stass AML; Hughes AM; Bell S; Proia TA; Wang Y; Ramos-Montoya A; Wali N; Carroll D; Singh M; Moschetta M; Gutierrez PM; Gardelli C; Critchlow SE; Klinowska T; Fawell SE; Barry ST
Mol Cancer Ther; 2021 Jun; 20(6):1080-1091. PubMed ID: 33785652
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle cells-derived CXCL10 prevents endothelial healing through PI3Kγ-dependent T cells response.
Lupieri A; Smirnova NF; Solinhac R; Malet N; Benamar M; Saoudi A; Santos-Zas I; Zeboudj L; Ait-Oufella H; Hirsch E; Ohayon P; Lhermusier T; Carrié D; Arnal JF; Ramel D; Gayral S; Laffargue M
Cardiovasc Res; 2020 Feb; 116(2):438-449. PubMed ID: 31106375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
